Painkiller XL is a modern hybrid-sativa cultivar bred directly from Royal Highness. Developed for its specific chemical composition, this strain balances its genetic architecture to prioritize a unique cannabinoid profile. It reaches harvest readiness in a 56-day flowering period, consistently providing high yields for growers operating in both indoor and outdoor environments. While cultivation requires a moderate skill level, the strain remains a reliable selection for those seeking professional-grade performance and stable development.

The aromatic and flavor profile of Painkiller XL is defined by its dominant concentration of terpinolene, which provides the foundation for its sensory experience. This is further nuanced by the secondary presence of myrcene and rounded out by a tertiary finish of caryophyllene. Together, these compounds create a distinct chemical profile that appeals to those sensitive to subtle botanical shifts, ensuring a consistent user experience rooted in the provided terpene hierarchy.

The cannabinoid profile of Painkiller XL is THC-dominant, containing approximately 9% THC alongside 0.3% CBD and 0.25% CBG. Users report that these levels produce effects characterized by creativity, uplifted mood, and happiness. Consequently, the strain is well-suited for activities requiring enhanced creativity, social engagement, or sustained focus. Currently, there is no recorded lineage of offspring derived from this cultivar, positioning it as a distinct end-point in its specific breeding line.